UNIVERSAL HEALTH REALTY INCOME TRUST (UHT) [Rocket]

Overview

UNIVERSAL HEALTH REALTY INCOME TRUST (UHT)

Add to portfolio

1m \| 3m \| 6m \| 1y \| 2y \| 5y \| 10y

Recent News + Filings (All items)

Date Filed	Type	Description
08/08/2023	10-Q	Quarterly Report for the period ended June 30, 2023
07/25/2023	8-K	Quarterly results
06/08/2023	4	Peterson Karla J (Vice President) has filed a Form 4 on UNIVERSAL HEALTH REALTY INCOME TRUST
06/08/2023	4	RAMAGANO CHERYL K (SVP, Operations and Treasurer) has filed a Form 4 on UNIVERSAL HEALTH REALTY INCOME TRUST
06/08/2023	4	BOYLE CHARLES F (Senior Vice President and CFO) has filed a Form 4 on UNIVERSAL HEALTH REALTY INCOME TRUST
06/08/2023	4	MILLER ALAN B (President, and CEO) has filed a Form 4 on UNIVERSAL HEALTH REALTY INCOME TRUST
06/08/2023	4	Guzman Rebecca A (Director) has filed a Form 4 on UNIVERSAL HEALTH REALTY INCOME TRUST

Revenue Mix by Segment

Financial Summary (All financials)

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15
Revenues	90.6	84.2	78.0	77.2	76.2	8.3	67.1	64.0
Revenue growth	7.6%	7.9%	1.1%	1.3%	818.2%	-87.6%	4.9%	7.0%
Cost of goods sold	60.0	55.3	52.0	4.0	3.8	0.1	0.5	0.2
Gross profit	30.7	28.9	26.0	73.2	72.4	8.2	66.6	63.7
Gross margin	33.8%	34.3%	33.3%	94.8%	95.0%	98.7%	99.2%	99.6%
Selling, general and administrative	0.0	0.0	0.0	47.4	45.7	44.6	41.2	49.0
EBITA	30.7	28.9	26.0	27.5	33.0	28.5	26.6	37.4
EBITA margin	33.8%	34.3%	33.3%	35.7%	43.3%	343.2%	39.6%	58.5%
Amortization of intangibles								5.5
EBIT	30.7	28.9	26.0	27.5	33.0	28.5	26.6	31.9
EBIT margin	33.8%	34.3%	33.3%	35.7%	43.3%	343.2%	39.6%	49.9%
Pre-tax income	21.1	109.2	19.4	19.0	24.2	45.6	17.2	23.7
Income taxes	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax rate	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Net income	21.1	109.2	19.4	19.0	24.2	45.6	17.2	23.7
Net margin	23.3%	129.7%	24.9%	24.6%	31.7%	549.6%	25.7%	37.0%

Diluted EPS	$1.53	$7.92	$1.41	$1.38	$1.76	$3.35	$1.28	$1.78
Shares outstanding (diluted)	13.8	13.8	13.8	13.8	13.7	13.6	13.5	13.3

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.